News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Corcept Therapeutics Inc (Symbol: CORT), where a total of 5,928 contracts have traded so far, representing approximately 592,800 underlying shares. That amounts to about 47.5% of CORT's average daily trading volume over the past month of 1.2 million shares. Particularly high volume was seen for the $27 strike call option expiring June 21, 2024, with 1,862 contracts trading so far today, representing approximately 186,200 underlying shares of CORT. Below is a chart showing CORT's trailing twelve month trading history, with the $27 strike highlighted in orange:

Toll Brothers Inc. (Symbol: TOL) options are showing a volume of 7,390 contracts thus far today. That number of contracts represents approximately 739,000 underlying shares, working out to a sizeable 47.3% of TOL's average daily trading volume over the past month, of 1.6 million shares. Particularly high volume was seen for the $120 strike call option expiring June 21, 2024, with 643 contracts trading so far today, representing approximately 64,300 underlying shares of TOL. Below is a chart showing TOL's trailing twelve month trading history, with the $120 strike highlighted in orange:

And Amgen Inc (Symbol: AMGN) saw options trading volume of 10,183 contracts, representing approximately 1.0 million underlying shares or approximately 46.9% of AMGN's average daily trading volume over the past month, of 2.2 million shares. Particularly high volume was seen for the $330 strike call option expiring January 17, 2025, with 1,673 contracts trading so far today, representing approximately 167,300 underlying shares of AMGN. Below is a chart showing AMGN's trailing twelve month trading history, with the $330 strike highlighted in orange:

For the various different available expirations for CORT options, TOL options, or AMGN options, visit StockOptionsChannel.com.

Also see:

ETF Channel
WWW Price Target
Institutional Holders of MRIN

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.